Iron-Deficiency Anemia in Castleman Disease: Implication of the Interleukin 6/Hepcidin Pathway
- 1 December 2010
- journal article
- case report
- Published by American Academy of Pediatrics (AAP) in Pediatrics
- Vol. 126 (6) , e1608-e1612
Abstract
In addition to occasional autoimmune hemolytic anemia, unexplained iron-deficiency anemia has been reported in childhood Castleman disease (CD). The recent discovery of hepcidin has regenerated the research on iron metabolism. This hormone is a key regulator of iron homeostasis, mainly by inhibiting intestinal iron absorption. Liver expression of hepcidin increases in response to interleukin 6 (IL-6). With chronic overproduction of IL-6 as a hallmark, CD could be an interesting human model for studying the contribution of the IL-6/hepcidin pathway in the pathogenesis of anemia of chronic disease. We report here the case of a 16-year-old boy with chronic iron-deficiency anemia (plasma ferritin: 19 μg/L; plasma iron: 2.2 μmol/L; negative bone marrow Perls' Prussian blue stain), inflammatory syndrome (C-reactive protein: 108 mg/L), and growth retardation for the previous 2 years. Diagnostic workup revealed a large mesenteric mass corresponding to localized CD of mixed histologic type. Resection of the tumor resulted in complete resolution of iron-deficiency anemia and inflammatory syndrome. Parallel variations of plasma IL-6, C-reactive protein, and hepcidin concentrations, together with tumor immunohistochemistry, strongly suggested that IL-6 synthesized by the tumor caused both the inflammation and iron deficiency through enhancement of hepcidin production by the liver. The results of this unique case study (1) explain the mechanism of iron deficiency observed in some children with CD, (2) confirm in vivo the regulatory effect of IL-6 in human hepcidin production, and (3) suggest that iron deficiency is a causal link between IL-6 and anemia of chronic disease.Keywords
This publication has 16 references indexed in Scilit:
- Immunoassay for human serum hepcidinBlood, 2008
- Hepcidin antimicrobial peptide transgenic mice exhibit features of the anemia of inflammationBlood, 2007
- Interleukin-6 induces hepcidin expression through STAT3Blood, 2006
- Paraneoplastic syndrome and intrathoracic Castleman diseasePediatric Blood & Cancer, 2005
- Anemia of Chronic DiseaseNew England Journal of Medicine, 2005
- Hepcidin Regulates Cellular Iron Efflux by Binding to Ferroportin and Inducing Its InternalizationScience, 2004
- IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidinJournal of Clinical Investigation, 2004
- Cytokine-mediated regulation of iron transport in human monocytic cellsBlood, 2003
- Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase proteinBlood, 2003
- Inappropriate expression of hepcidin is associated with iron refractory anemia: implications for the anemia of chronic diseaseBlood, 2002